Sunday, January 15, 2023 2:23:24 PM
Im of the opinion that 2 million shares of cvsi were given to Stuart sometime around
December 8th 2022. I'm also of the opinion that everything is now outsourced (sorry wolfman) and thats by design. Thats why we would fit perfectly into a acquisition or partnership by a company that already
does manufacturing and packaging.. Nordic Naturals at first glance would seem a perfect
fit. CVSi hemp is sourced from the Netherlands. Nordic Pharma manufactures the Omega 3
in Norway. I would think they could process the hemp oil along with a fish oil and send it to
San Diego..
From Nordic Naturals:
All of our liquid and soft gel products are bottled and encapsulated at our plant in Southern California.( I've seen San Diego listed as the specific city)
December 8th 2022. I'm also of the opinion that everything is now outsourced (sorry wolfman) and thats by design. Thats why we would fit perfectly into a acquisition or partnership by a company that already
does manufacturing and packaging.. Nordic Naturals at first glance would seem a perfect
fit. CVSi hemp is sourced from the Netherlands. Nordic Pharma manufactures the Omega 3
in Norway. I would think they could process the hemp oil along with a fish oil and send it to
San Diego..
From Nordic Naturals:
All of our liquid and soft gel products are bottled and encapsulated at our plant in Southern California.( I've seen San Diego listed as the specific city)
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
